Medicine and Dentistry
Adrenergic Receptor Blocking
29%
Anal Fistula
52%
Anastomosis Leakage
60%
Antibiotics
18%
Biological Marker
22%
Bowel Obstruction
18%
Breast Cancer
21%
Chemoradiotherapy
31%
Colectomy
95%
Colon
27%
Colon Anastomosis
18%
Colon Surgery
45%
Colonoscopy
32%
Coloproctology
17%
Colorectal Carcinoma
68%
Colorectal Surgery
61%
Colostomy
23%
COVID-19
28%
Crohn's Disease
74%
Cyclooxygenase 2 Inhibitor
19%
Diseases
46%
Diverticulitis
42%
Diverticulum
19%
Etodolac
24%
Fibrin Glue
23%
Fistula
56%
Hemicolectomy
25%
Hernioplasty
28%
Ileo-Anal Pouch
28%
Infectious Complication
19%
Inguinal Hernia
21%
Intestine Preparation
56%
Laparoscopic Surgery
72%
Laparotomy
50%
Lymph Node
20%
Malignant Neoplasm
40%
Metastatic Carcinoma
62%
Mortality Rate
18%
Neoplasm
65%
Patient with Crohn's Disease
25%
Placebo
34%
Postoperative Complication
71%
Propranolol
24%
Rectum Cancer
56%
Rectum Resection
22%
Rectum Surgery
33%
Recurrent Disease
49%
Surgeon
74%
Surgical Anastomosis
53%
Surgical Technique
32%
Keyphrases
5-year Survival
22%
Acute Diverticulitis
23%
Adrenergic Blockade
22%
After Surgery
26%
Anastomotic Leak
63%
Before Surgery
25%
Breast Cancer Patients
21%
Colon
38%
Colon Resection
39%
Colon Surgery
30%
Colonoscopy
25%
Colorectal Anastomosis
29%
Colorectal Cancer
100%
Colorectal Resection
23%
Colorectal Surgery
80%
Complication Rate
43%
Crohn's
20%
Crohn's Disease
83%
Cyclooxygenase-2
35%
Etodolac
35%
Fibrin Glue
22%
Fistula
35%
Healing
22%
Inflammatory Bowel Disease
21%
Laparoscopic Approach
38%
Laparoscopic Colectomy
44%
Laparoscopic Colorectal Surgery
21%
Laparoscopic Surgery
40%
Laparoscopy
42%
Laparotomy
33%
Left-handed
28%
Length of Hospital Stay
27%
Mechanical Bowel Preparation
49%
Operative Time
21%
Perianal Fistula
38%
Postoperative Complications
56%
Postoperative Outcomes
29%
Propranolol
32%
Prospective Audit
37%
Prospective Randomized Trial
21%
Recurrence Rate
22%
Resection
29%
Right Hemicolectomy
22%
Risk Factors
29%
Standard of Care
29%
Surgeons
57%
Surgical Outcomes
26%
Surgical Procedures
27%
Surgical Treatment
20%
Tumor
38%